Emergency Medicine and the Public's Health: Emerging Infectious Diseases

Emergency Medicine Clinics of North America

Volumn 24, Issue 4, 2006, Pages 1019-1033

  Saks, Mark A ^a   Karras, David ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; BIOLOGICAL WARFARE; CLINICAL FEATURE; DISEASE TRANSMISSION; EBOLA VIRUS; EMERGENCY HEALTH SERVICE; EPIDEMIC; HANTAVIRUS; HIGH RISK POPULATION; HUMAN; IMMIGRANT; INFECTION; INFECTION RISK; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALLPOX; SMALLPOX VIRUS; SYMPTOMATOLOGY; UNITED STATES; VIRUS HEMORRHAGIC FEVER; WEST NILE FLAVIVIRUS;

EID: 33748607690     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2006.06.005     Document Type: Review

References (76)

1. Institute of Medicine. Emerging infections: microbial threats to health in the United States (1994), National Academy Press, Washington, DC
2. Colebunders R., and Borchert M. Ebola haemorrhagic fever-a review. J Infect 40 (2000) 16-20
3. Lee L.M., and Henderson D.K. Emerging viral infections. Curr Opin Infect Dis 14 4 (2001) 467-480
4. Rollin P.E., Williams R.J., Bressler D.S., et al. Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 179 (1999) S108-S114
5. Vogel J. Ebola outbreaks may have had independent sources. Science 303 (2004) 298-299
6. Thacker P.D. An Ebola epidemic simmers in Africa: in remote region, outbreak shows staying power. JAMA 290 3 (2003) 317-319
7. Leroy E.M., Telfer P., Kumulungui B., et al. A serological survey of Ebola virus infection in Central African nonhuman primates. J Infect Dis 190 (2004) 1895-1899
8. Swanepoel R., Leman P.A., and Burt F.J. Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis 2 (1996) 321-325
9. Busico K.M., Marshall K.L., Ksiazek T.G., et al. Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. J Infect Dis 179 (1999) S98-S101
10. Peters C.J., and LeDuc J.W. An introduction to Ebola: the virus and the disease. J Infect Dis 179 (1999) S9-S16
11. Centers for Disease Control and Prevention. Outbreak of Ebola hemorrhagic fever-Uganda, August 2000-January 2001. MMWR 50 5 (2001) 73-77
12. Dowell S.F. Ebola hemorrhagic fever: why were children spared?. Pediatr Infect Dis J 15 3 (1996) 189-191
13. Varkey P., Poland G.A., Cockerill F.R., et al. Confronting bioterrorism: physicians on the front line. Mayo Clin Proc 77 7 (2002) 661-672
14. Bray M., and Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis 118 (2003) 1613-1617
15. Richards G.A., Murphy S., Jobson R., et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiological aspects. Crit Care Med 28 1 (2000) 240-244
16. Sanchez A., Lukwiya M., Bausch D., et al. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 78 19 (2004) 10370-10377
17. Borio L., Inglesby T., Peters C.J., et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287 18 (2002) 2391-2405
18. Drosten C., Kümmerer B.M., Schmitz H., et al. Molecular diagnostics of viral hemorrhagic fevers. Antiviral 57 (2003) 61-87
19. Towner J.S., Rollin P.E., Bausch D.G., et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 78 8 (2004) 4330-4341
20. Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent. MMWR 50 (2001) 893-897
21. Isaäcson M. Viral hemorrhagic fever hazards for travelers in Africa. CID 33 (2001) 1707-1712
22. Ryan E.T., Wilson M.E., and Kain K.C. Illness after international travel. N Engl J Med 347 7 (2002) 505-516
23. Centers for Disease Control and Prevention. Outbreak of acute illness-Southwestern United States. MMWR 42 (1993) 421-424
24. Duchin J.S., Koster F.T., Peters C.J., et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med 330 14 (1994) 949-955
25. Mills J.N., Yates T.L., Ksiazek T.G., et al. Long-term studies of Hantavirus reservoir populations in the Southwestern United States: rationale, potential, and methods. Emerg Infect Dis 5 1 (1999)
26. Childs J.E., Ksiazek T.G., Spiropoulou C.F., et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new Hantavirus in the Southwestern United States. J Infect Dis 169 (1994) 1271-1280
27. Tsai T.F. Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab Anim Sci 37 (1987) 428-430
28. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome-Panama, 1999-2000. MMWR 283 17 (2000) 2232-2233
29. Armstrong L.R., Zaki S.R., Goldoft M.J., et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. J Infect Dis 171 4 (1995) 864-870
30. Centers for Disease Control and Prevention. Update: Hantavirus pulmonary syndrome-United States, 1999. MMWR 48 24 (1999) 521-525
31. Wells R.M., Estani S.S., Yadon Z.E., et al. An unusual Hantavirus outbreak in southern Argentina: person-to-person transmission?. Emerg Infect Dis 3 2 (1997) 171-174
32. Ferres M., and Vial P. Hantavirus infection in children. Curr Opin Pediatr 16 1 (2004) 70-75
33. Doyle T.J., Bryan R.T., and Peters C.J. Viral hemorrhagic fevers and Hantavirus infections in the Americas. Infect Dis Clin North Am 12 1 (1998) 95-110
34. Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome-Vermont 2000. MMWR 50 (2001) 603-605
35. White D.J., Means R.G., Birkhead G.S., et al. Human and rodent Hantavirus infection in New York State: public health significance of an emerging infectious disease. Arch Intern Med 156 7 (1996) 722-726
36. Wasser W.G., Rossi C.A., and Glass G.E. Hantavirus antibodies in New York. Ann Intern Med 127 2 (1997) 166-167
37. Hallin G.W., Simpson S.Q., Crowell R.E., et al. Cardiopulmonary manifestations of Hantavirus pulmonary syndrome. Crit Care Med 24 2 (1996) 251-258
38. Mertz G., Hjelle B., and Bryan R. Hantavirus infection. Adv Intern Med 42 (1997) 369-421
39. Koster F., Foucar K., Hjelle B., et al. Rapid presumptive diagnosis of Hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am J Clin Pathol 116 (2001) 665-672
40. Bostik P., Winter J., Ksiazek T.G., et al. Sin Nombre Virus (SNV) Ig isotype antibody response during acute and convalescent phases of Hantavirus pulmonary syndrome. Emerg Infect Dis 6 2 (2000)
41. Crowley M.R., Katz R.W., Kessler R., et al. Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Crit Care Med 26 2 (1998) 409-414
42. Peters C.J., Ali S., and Sherif R. Hantaviruses in the United States. Arch Intern Med 156 7 (1996) 705-707
43. Eyler J.M. Smallpox in history: the birth, death, and impact of a dread disease. J Lab Clin Med 142 4 (2003) 216-220
44. Wollenberg A., and Engler R. Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr Opin Allergy Clin Immunol 4 4 (2004) 271-275
45. Johnson R.T. Smallpox: the threat of bioterrorism and the risk of the vaccine. Neurology 60 8 (2003) 1228-1229
46. Centers for Disease Control and Prevention. Recommendations of the Public Health Service Advisory Committee on Immunization Practices: smallpox vaccination of hospital and health personnel. MMWR 25 (1976) 8-9
47. Fenner F., Henderson D.A., Arita I., et al. Smallpox and its eradication (1998), World Health Organization, Geneva. http://www.who.int/emc/diseases/smallpox/Smallpoxeradication.html Accessed February 14, 2006
48. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR 50 R10 (2001) 1-25
49. Institute of Medicine. Review of the Centers for Disease Control and Prevention's smallpox vaccination program implementation-Letter Report #1 (2003), National Academy of Sciences, Washington, DC
50. Benin A.L., Dembry L., Shapiro E.D., et al. Reasons physicians accepted or declined smallpox vaccine February through April, 2003. J Gen Intern Med 19 (2004) 85-89
51. Jefferson T. Editorial: bioterrorism and compulsory vaccination. BMJ 329 (2004) 524-525
52. Centers for Disease Control and Prevention. Secondary and tertiary transfer of Vaccinia virus among US military personnel-United States and worldwide, 2002-2004. MMWR 53 05 (2004) 103-105
53. Thorne C.D., Hirshon J.M., Himes C.D., et al. Emergency medicine tools to manage smallpox (vaccinia) vaccination complications: clinical practice guideline and policies and procedures. Ann Emerg Med 42 5 (2003) 665-681
54. Aragón T.J., Ulrich S., Fernyak S.E., et al. Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968 (2003), BMC Public Health. Available at: http://biomedcentral.com/1471-2458/3/26 Accessed February 14, 2006
55. Arness M.K., Eckart R.E., Love S.S., et al. Myopericarditis following smallpox vaccination. Am J Epid 160 7 (2004) 642-651
56. Aragón T.J., and Fernyak S.E. The risks and benefits of pre-event smallpox vaccination: where you stand depends on where you sit. Ann Emerg Med 42 5 (2003) 681-684
57. Centers for Disease Control and Prevention. Cardiac adverse events following smallpox vaccination-United States, 2003. MMWR 52 12 (2003) 248-250
58. Centers for Disease Control and Prevention. Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry-United States, 2003. MMWR 52 17 (2003) 386-388
59. Centers for Disease Control and Prevention. Smallpox: Images. Available at: http://www.bt.cdc.gov/agent/smallpox/smallpox-images/. Accessed February 14, 2005.
60. Centers for Disease Control and Prevention. Outbreak of West Nile-like virus-New York, 1999. MMWR Morb Mortal Wkly Rep 48 (1999) 845-849
61. Nash D., Mostashari F., Fine A., et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 344 (2001) 1807-1814
62. Hubalek Z., and Halouzka J. West Nile Fever-a reemerging mosquito borne viral disease in Europe. Emerg Infect Dis 5 (1999) 643-650
63. Rappole J.H., Derickson S.R., and Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis 6 (2000) 319-328
64. Lanciotti R.S., Roehrig J.T., Deubel V., et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the Northeastern United States. Science 286 (1999) 2333-2337
65. Tyler K.L. Editorial: West Nile Virus encephalitis in America. N Engl J Med 344 24 (2001) 1858-1859
66. Centers for Disease Control and Prevention. West Nile Virus-Statistics, Surveillance, and Control. http://www.cdc.gov/ncidod/dvbid/westnile/surv&control04Maps.htm. Accessed March 10, 2005.
67. Goetz A.M., and Goldrick B. West Nile virus: a primer for infection control professionals. Am J Infect Control 32 2 (2004) 101-105
68. Petersen L., and Marfin A.A. West Nile virus: a primer for the clinician. Ann Intern Med 137 3 (2002) 173-179
69. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 348 (2003) 2196-2203
70. Centers for Disease Control and Prevention. Possible West Nile virus transmission to an infant through breast-feeding-Michigan, 2002. MMWR 51 (2002) 877-878
71. Sampathkumar P. West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention. Mayo Clin Proc 78 9 (2003) 1137-1144
72. Mostashari F., Bunning M.L., Kitsutani P.T., et al. Epidemic West Nile encephalitis, New York 1999: results of a household-based seroepidemiological survey. Lancet 358 (2001) 261-264
73. Centers for Disease Control and Prevention. West Nile Virus-Information and Guidance for Clinicians. http://www.cdc.gov/ncidod/dvbid/westnile/clinicians/pdf/wnv-clinicaldesc ription.pdf. Accessed February 14, 2005.
74. Hammerschlag M.R. West Nile virus: from epidemic to endemic. Infect Med 20 8 (2003) 374-375
75. Gea-Banacloche J., Johnson R.T., Bagic A., et al. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med 140 7 (2004) 545-553
76. Solomon T., Ooi M.H., Beasley D.W., et al. West Nile encephalitis. BMJ 326 (2003) 865-869